Filing Details
- Accession Number:
- 0001131096-15-000136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-29 17:35:26
- Reporting Period:
- 2015-07-27
- Filing Date:
- 2015-07-29
- Accepted Time:
- 2015-07-29 17:35:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131096 | Athenahealth Inc | ATHN | Services-Business Services, Nec (7389) | 043387530 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1049356 | A John Kane | C/O Athenahealth, Inc. 311 Arsenal Street Watertown MA 02472 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-27 | 2,875 | $15.27 | 9,496 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-07-27 | 700 | $129.09 | 8,796 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-27 | 300 | $129.97 | 8,496 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-27 | 1,875 | $131.50 | 6,621 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-07-27 | 2,875 | $0.00 | 2,875 | $15.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,500 | 2007-07-26 | 2017-07-26 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2015, in accordance with Rule 10b5-1.
- This price represents the weighted average of sales ranging from $128.56 to $129.39. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average of sales ranging from $129.60 to $130.31. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average of sales ranging from $130.97 to $131.55. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.